Release Date: 2024-06-19

Current Management of Metastatic Prostate Cancer

Asif YILDIRIM (Editor), Ozgur KAZAN (Editor), Ahmet KELES (Editor), Mehmet Caglar CAKICI (Editor)
Release Date: 2024-06-19
Media Type

Buy from

Price may vary by retailers

Work TypeEdited Book
Internal Reference
Edition1
DOIhttps://doi.org/10.69860/nobel.9786053359142
ISBN978-605-335-914-2 (PAPERBACK)
Language
Page Count
Print Lenght
Place
Copyright HolderNobel Tıp Kitabevleri
Licensehttps://nobelpub.com/publish-with-us/copyright-and-licensing
BICMJCL
BISACMED062000
THEMAMJCL
Keywordsoncology, radiation theraphy, urology
CategoryOncolgy
Current Management of Metastatic Prostate Cancer
  1. Histopathological and Molecular Markers of Metastatic Prostate Cancer
    Nagehan Ersoy Tunalı, Ceyda Nur Zaim
  2. Lhrh Agonist and Antagonist for Metastatic Prostate Cancer
    Bekir Demirtas, Ozgur KAZAN
  3. Radical Prostatectomy As a Local Therapy in the Management of Patients with Oligometastatic Prostate Cancer
    Ferhat Keser, Mehmet Caglar CAKICI
  4. Role of Metastasectomy in Prostate Cancer Patients Following Curative Treatment
    Ahmet KELES, Burak Tufekci
  5. Radiotherapy As a Local Therapy in the Management of Patient with Oligometastatic Prostate Cancer
    Ayberk Iplikci, Ozgur Efiloglu
  6. Systemic Chemotherapy for Metastatic Prostate Cancer
    Selamettin Demir, Muhammet Cicek
  7. Enzalutamide Therapy for Metastatic Prostate Cancer
    Turgay Turan, Yunus Erol Bozkurt
  8. Abiraterone Acetate Treatment in Metastatic Prostate Cancer
    Hakan Polat, Yavuz Onur Danacıoğlu
  9. Apalutamide Therapy for Metastatic Prostate Cancer
    Eyyüp Sabri Pelit, Mustafa Kaan Akalin
  10. Darolutamide Therapy for Metastatic Prostate Cancer
    Kenan Toprak, Meftun Culpan
  11. Parp Inhibitors Therapy for Metastatic Prostate Cancer
    Erdinç Dinçer, Cengiz Canakci
  12. Combined Treatments for Metastatic Prostate Cancer
    Onur Alkan, Sinan Koca
  13. Immunotherapy for Prostate Cancer
    Ilkin Hamid-zada, Ozgur Arikan
  14. Rational Sequential Treatment Options for Metastatic Prostate Cancer
    Aydın Acarbey, Mahmut Gümüş
  15. Bone Health and Bone Targeted Therapies for Metastatic Prostate Cancer
    Halil Lütfi Canat, Adem Alcin
  16. Quality of Life Outcomes After the Management of Metastatic Prostate Cancer
    Alpaslan Yuksel, Elbrus Fehruzlu
  17. Management of Brain Metastasis in Patients with Metastatic Prostate Cancer
    Berin Gülatar Türkoğlu, Kadriye Ağan Yıldırım
  18. Palliative Care for Metastatic Prostate Cancer
    Ferhat Yakup Suçeken, Ahmet Tahra

Yıldırım, Asif (Editor)
Professor, Istanbul Medeniyet University
https://orcid.org/0000-0002-3386-971X
3Dr. Yildirim received his Doctor of Medicine from the Marmara University School of Medicine and started the residency training in the Department of Urology at the Marmara University School of Medicine in 1995. He completed his urological residency in 2000. He earned the degrees of Associate Professor in 2010, and Professor of Urology in 2016, and by February 2016 he joined the Department of Urology at Medical School of Medeniyet University. Dr. Yildirim specialized in the treatment of genitourinary cancers, including prostate cancer, bladder cancer, renal cancer and testicular cancer. His research interests include imaging, pathology and genetics of prostate cancer, bladder cancer and renal cancer.

Kazan, Özgür (Editor)
Istanbul Medeniyet University
https://orcid.org/0000-0003-0202-0454
3Huseyin Ozgur Kazan, M.D., FEBU, is a dedicated urologist specializing in urooncology, proficient in diverse surgical techniques including laparoscopic and endoscopic procedures. With a commitment to patient-centered care, he continuously enhances his expertise through ongoing professional development and clinical research. Fluent in English and German, he graduated from Ege University Faculty of Medicine and completed his residency at Istanbul Medeniyet University Faculty of Medicine Prof. Dr. Süleyman Yalçın City Hospital. His professional journey includes roles at various hospitals, including Kocaeli State Hospital and Kütahya Health Sciences University Evliya Çelebi Training and Research Hospital. Currently, he serves as a Urology Specialist at Istanbul Medeniyet University Faculty of Medicine Prof. Dr. Süleyman Yalçın City Hospital. Notably, his research, supported by TÜBİTAK, focused on the prognostic role of PI3K and JAK/STAT pathways in regulating PDL-1 expression in prostate cancer.

Keleş, Ahmet (Editor)
Istanbul Medeniyet University
https://orcid.org/0000-0001-5436-1803
3Dr. Ahmet Keles earned his Doctor of Medicine (MD) degree from Akdeniz University School of Medicine and completed his residency in residency in the Department of Urology at Marmara University Faculty of Medicine. During his residency, he achieved certification in European Basic Laparoscopic Urological Skills (E-BLUS) and became a Fellow of the European Board of Urology (FEBU). To further specialize, Dr. Keles underwent rigorous endourology training under Prof. Dr. Jean de la Rosette at Amsterdam Academic Medical Center (AMC) through the prestigious European Urological Scholarship Programme (EUSP). Currently, he is expanding his expertise as a Urologist at Istanbul Medeniyet University Faculty of Medicine. Dr. Keles's research has resulted in nearly 30 scientific publications in peer-reviewed journals and numerous presentations at national and international conferences. Additionally, he has contributed to the field by authoring six book chapters in urology and oncology. He is also a member of the European Association of Urology (EAU) and the American Urological Association (AUA).

Çakıcı, Mehmet Çağlar (Editor)
Associate Professor, Istanbul Medeniyet University
https://orcid.org/0000-0002-0176-5887
3Mehmet Çağlar Çakıcı completed his undergraduate education at Gazi University Faculty of Medicine in 2012. He finished his urology specialization training in 2018 at Ankara Diskapi Yildirim Beyazit Training and Research Hospital. In the same year, he started working as a urology specialist at Istanbul Medeniyet University Goztepe Training and Research Hospital, and he currently continues his work at the same hospital as an associate professor. He has authored over seventy articles and participated as an investigator in ten clinical studies.

reviews

Reviews

There are no reviews yet.

Be the first to review “Current Management of Metastatic Prostate Cancer”

Your email address will not be published. Required fields are marked *

Share This Book!